Tiea L. Kesler

Ms Kesler earned her degree from East Carolina University and completed her cytology education at the University of North Carolina at Chapel Hill School of Medicine. She holds certification from the American Society for Clinical Pathology (ASCP) Board of Registry as a cytotechnologist (CT). She has over 30 years of experience in the field of cytology dedicating her career to Labcorp. Ms Kesler participates in the Women’s Health Advisory Committee, where she has been involved in reviewing the competitive and breakthrough strategies and planning for cytology and wom

Tiea L. Kesler

Ms Kesler earned her degree from East Carolina University and completed her cytology education at the University of North Carolina at Chapel Hill School of Medicine. She holds certification from the American Society for Clinical Pathology (ASCP) Board of Registry as a cytotechnologist (CT). She has over 30 years of experience in the field of cytology dedicating her career to Labcorp. Ms Kesler participates in the Women’s Health Advisory Committee, where she has been involved in reviewing the competitive and breakthrough strategies and planning for cytology and women’s health

Stuart Schwartz, PhD

Dr Schwartz is board certified in medical genetics, clinical cytogenetics, and clinical molecular genetics. He earned a PhD in medical genetics from Indiana University and completed a postdoctoral fellowship at the University of Maryland School of Medicine.

Stuart Schwartz, PhD

Dr Schwartz is board certified in medical genetics, clinical cytogenetics, and clinical molecular genetics. He earned a PhD in medical genetics from Indiana University and completed a postdoctoral fellowship at the University of Maryland School of Medicine.

Stefan Tiefenbacher, PhD

Dr Tiefenbacher graduated from the University of Massachusetts with a PhD in neuroscience and behavior in 2002. He completed fellowships in psychiatry and pharmacology at Harvard Medical School and the University of Colorado Health Sciences Center. Dr Tiefenbacher joined the Colorado Coagulation team as Scientific Director in 2005.

Stefan Tiefenbacher, PhD

Dr Tiefenbacher graduated from the University of Massachusetts with a PhD in neuroscience and behavior in 2002. He completed fellowships in psychiatry and pharmacology at Harvard Medical School and the University of Colorado Health Sciences Center. Dr Tiefenbacher joined the Colorado Coagulation team as Scientific Director in 2005.

Sean E. Farrier, MD

Dr Farrier is board certified in anatomic and clinical pathology. He earned his medical degree from the University of South Florida. He completed residency training in the Department of Pathology, University of South Florida, Tampa General Hospital.

Sean E. Farrier, MD

Dr Farrier is board certified in anatomic and clinical pathology. He earned his medical degree from the University of South Florida. He completed residency training in the Department of Pathology, University of South Florida, Tampa General Hospital.

Sanjai Nagendra, MD, MMM

Dr Nagendra is a physician executive with more than fifteen years of clinical and leadership experience. After graduating from the University of Iowa College of Medicine, he completed a combined anatomic and clinical pathology residency and a hematopathology fellowship at the University of Iowa Hospitals and Clinics. He is a senior hematopathologist with sixteen years of experience interpreting benign and malignant disorders.

Sanjai Nagendra, MD, MMM

Dr Nagendra is a physician executive with more than fifteen years of clinical and leadership experience. After graduating from the University of Iowa College of Medicine, he completed a combined anatomic and clinical pathology residency and a hematopathology fellowship at the University of Iowa Hospitals and Clinics. He is a senior hematopathologist with sixteen years of experience interpreting benign and malignant disorders.